Prof Ursula Schmidt-Erfurth – a breakdown of the data from the VIEW and HARBOR trials. Structural comparisons, visual outcomes, fellow eye data and implications for clinical practice
Prof Robyn Guymer – High risk predictors of macular degenerative atrophy on OCT. A discussion of reticular pseudo-drusen, non-geographic atrophy, hyper-reflective foci and outer retinal morphology.
A/Prof Hunyor – management of pigment epithelial detachment (PED). Categories of PED, imaging of PED and management strategies.
A/Prof Chen – Where are we with retinal replacement therapies and treatment for non-neovascular AMD. A whirlwind tour through pluripotent stem cells, retinal prostheses, gene therapy and neuroprotective agents.
IRREVERSIBLE LENALIDOMIDE RELATED OPTIC NEUROPATHY IN A PATIENT WITH CHRONIC MYELOID LEUKAEMIA
A cost-effectiveness analysis of AcrySof IQ vivity intraocular lens from private health fund perspective in Australia
Efficacy and safety of intravitreal pegcetacoplan in geographic atrophy: Results from the phase 3 DERBY and OAKS trials